Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...

Only a few dozen patients with lupus have been treated with CAR-T-cell therapy — but in a small German study, all five ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

CAR T-cell therapy re-engineers immune cells to target and eradicate high-risk blood cancers, offering potential cures where traditional chemotherapy fails. Initially requiring inpatient care due to ...

CAR-T cell therapy has cured some children with blood cancers and is being studied in solid tumors, where responses differ due to how these cancers grow. CAR-T cell therapy has cured some children ...

In a groundbreaking development for cancer treatment, Caribou Biosciences announced promising results from its off-the-shelf CAR-T therapy in patients with advanced B-cell lymphoma. This innovative ...

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers.

Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid cancers - but a study in mice suggests that could soon change ...

Allogene Therapeutics ( ($ALLO) ) has released its Q3 earnings. Here is a breakdown of the information Allogene Therapeutics presented to its ...

The global car t-cell therapy market size is predicted to increase from USD 7.64 billion in 2025 and is anticipated to be ...